当前位置:首页 - 行情中心 - 福安药业(300194) - 财务分析 - 现金流量表

福安药业

(300194)

  

流通市值:49.55亿  总市值:60.91亿
流通股本:9.68亿   总股本:11.90亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,928,284,744.741,373,536,327.59754,433,823.992,568,631,827.73
收到的税费返还4,589,186.453,478,352.881,132,310.2310,732,630.48
收到其他与经营活动有关的现金69,043,617.541,285,907.9721,803,368.25106,114,773.2
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,001,917,548.691,418,300,588.44777,369,502.472,685,479,231.41
购买商品、接受劳务支付的现金571,872,263.31346,685,718.93155,325,679.24733,630,263.05
支付给职工以及为职工支付的现金349,457,165.81244,788,038.77145,478,877.28433,146,029.14
支付的各项税费172,189,652.7131,886,974.5775,319,193.61209,015,471.81
支付其他与经营活动有关的现金607,554,180.64447,593,251.55246,672,173.2980,709,340.56
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,701,073,262.461,170,953,983.82622,795,923.332,356,501,104.56
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额300,844,286.23247,346,604.62154,573,579.14328,978,126.85
二、投资活动产生的现金流量:
收回投资收到的现金25,000,0005,000,0005,000,00054,000,800
取得投资收益收到的现金42,303,272.5242,254,107.72259,362.34641,890.76
处置固定资产、无形资产和其他长期资产收回的现金净额330,599.21182,140.5130,020122,667,526.1
收到的其他与投资活动有关的现金10,265,254.6210,185,254.6210,000,0005,097,535.4
投资活动现金流入的平衡项目0000
投资活动现金流入小计77,899,126.3557,621,502.8415,389,382.34182,407,752.26
购建固定资产、无形资产和其他长期资产支付的现金166,772,972.38116,439,153.9865,025,878.13215,679,559.75
投资支付的现金50,000,0000-50,350,000
支付其他与投资活动有关的现金51,220,101.9746,407,70046,407,70010,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计267,993,074.35162,846,853.98111,433,578.13276,029,559.75
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-190,093,948-105,225,351.14-96,044,195.79-93,621,807.49
三、筹资活动产生的现金流量:
取得借款收到的现金498,159,804.54408,500,000338,136,141.65848,080,000
收到其他与筹资活动有关的现金11,172,442.753,324,029.5933,876.045,032,661.67
筹资活动现金流入平衡项目0000
筹资活动现金流入小计509,332,247.29411,824,029.59338,170,017.69853,112,661.67
偿还债务支付的现金624,110,200548,110,200430,820,000705,284,464
分配股利、利润或偿付利息支付的现金78,887,456.1873,535,496.198,739,977.1893,981,544.64
支付其他与筹资活动有关的现金19,421,023.628,050,400.91215,870.927,592,933.2
筹资活动现金流出平衡项目0000
筹资活动现金流出小计722,418,679.8629,696,097.1439,775,848.1806,858,941.84
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-213,086,432.51-217,872,067.51-101,605,830.4146,253,719.83
四、汇率变动对现金及现金等价物的影响640,467.83596,904.94303,504.6878,465.52
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-101,695,626.45-75,153,909.09-42,772,942.46282,488,504.71
加:期初现金及现金等价物余额936,543,376.57936,543,376.57936,543,376.57654,054,871.86
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额834,847,750.12861,389,467.48893,770,434.11936,543,376.57
补充资料:
净利润-215,551,972.95-234,408,732.4
资产减值准备-4,340,371.75-241,667,187.25
固定资产和投资性房地产折旧-77,676,561.3-150,833,665.78
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-77,676,561.3-150,833,665.78
无形资产摊销-19,567,342.58-57,534,348.42
长期待摊费用摊销-309,379.02-718,208.29
处置固定资产、无形资产和其他长期资产的损失--142,005.09--220,653,129.81
固定资产报废损失-848,572.62-1,349,774.91
公允价值变动损失----408,339.51
财务费用-11,923,592.19-24,730,875.71
投资损失--42,244,671.48--77,393,502.73
递延所得税-5,915,353.63-22,785,712.21
其中:递延所得税资产减少-7,731,046.72-36,050,809.71
递延所得税负债增加--1,815,693.09--13,265,097.5
存货的减少--65,589,577.46-9,200,808.16
经营性应收项目的减少--25,355,941.44-71,852,383.19
经营性应付项目的增加-44,034,420.14--193,145,165.76
其他---4,796,190.28
现金的期末余额-861,389,467.48-936,543,376.57
减:现金的期初余额-936,543,376.57-654,054,871.86
公告日期2024-10-252024-08-292024-04-252024-04-25
审计意见(境内)标准无保留意见
TOP↑